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ABSTRACT 
L-3,4-dihydroxyphenylalanine (L-DOPA) alleviates the motor symptoms of 
Parkinson's disease (PD), but its long-term use is associated with 
underirable dyskinesia. We now tested whether exercise can attenuate these 
L-DOPA-induced dyskinesia (LID). We tested the effects of exercise on L-
DOPA-induced dyskinesia (LID) in 6-OHDA-hemiparkinsonian mice. 
Animals were treated with L-DOPA/benserazide (25/12.5 mg/kg, i.p.) 
without and with possibility to exercise (running wheel) during two weeks. 
Exercise drasticaly prevented the development of LID, and its associated 
aberrant striatal signaling, namely the hyperphosphorylation of dopamine 
and cAMP regulated phosphoprotein 32 kDa (DARPP-32) protein and c-
Fos expression. Our results indicate that exercise can partially prevent the 
development of LID through the normalization of striatopallidal 
dopaminergic signaling. 
 
Key-words: DARPP-32; dyskinesia; exercise; L-DOPA; Parkinson’s 
disease; 6-OHDA. 
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1. INTRODUCTION 
The nigrostriatal pathway provides the source of dopamine (DA) to the 
striatum, as part of basal ganglia motor loop, which is involved in the 
control of movements (Holschneider et al., 2007). In Parkinson’s disease 
(PD), nigrostriatal neurons degenerate and supplementation with oral L-3,4-
dihydroxyphenylalanine (L-DOPA), a DA precursor, is the main clinical 
strategy to counteract the motor symptoms of PD and improve 
rehabilitation (Blonsky and Minnigh, 1970, Mikkelsen et al., 1972). 
However, long-term L-DOPA treatment induces the development of severe 
dyskinesia (Parkes, 1981), an important socio-economic cause of distress 
for PD patients (Maurel et al., 2001). The pathophysiology of L-DOPA-
induced dyskinesia (LID) remains unknown, but neurochemical studies 
have pinpointed the association of LID with a sustained activation of cdk5 
(cyclin-dependent kinase 5) and DARPP-32 signaling (DA- and cAMP-
regulated neuronal phosphoprotein, 32 kDa), and an increased expression 
of FosB and prodynorphin in striatopallidal GABAergic medium-sized 
spiny neurons (MSNs) (Andersson et al., 1999, Picconi et al., 2003). Albeit 
LID is common, they are difficult to treat, since therapeutic options to 
manage dyskinesia are scarce. Amantadine, a glutamate NMDA receptor 
antagonist, is the only approved pharmacotherapy (Lundblad et al., 2005), 
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as an alternative to the expensive and complex deep brain stimulation or 
continuous infusion of dopaminergic drugs (Cenci, 2007). 
Along with L-DOPA, exercise can also stimulate and normalize 
motor function in animal models of PD (Aguiar et al., 2009, VanLeeuwen 
et al., 2010). In particular, exercise reduces stereotypic movements (Klusha 
et al., 1983, Dey and Singh, 1992, Teixeira et al., 2008), the 
phosphorylation of DARPP-32 (Aguiar et al., 2010) and the expression of 
c-Fos in the murine striatum (Liste et al., 1997). However, since the effects 
of exercise on LID are unknown, we now investigated the effects of 
exercise in the development of LID in an experimental model of PD. 
 
2. METHODS 
 This study was approved by the UFSC Ethics Committee, which 
follows National Research Council principles (USA). All drugs were 
purchased from Sigma Aldrich and were freshly diluted in isotonic saline 
(0.9% NaCl). The injection volume was always 0.1 mL/10 g body weight. 
The schedule of drug treatment and behavioral tasks is illustrated in fig.1A. 
 
2.1. Hemiparkinsonism, dyskinesia and exercise 
We used C57BL/6 mice (male, 8-10 weeks old, weighted 20-35 g) 
from our own inbred colony, housed on a 12/12-h light/dark cycle (lights 
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ON 7 A.M.), room temperature 21±1°C, with ad libitum access to food and 
water. 
6-Hydroxydopamine hydrochloride (6-OHDA, 3 µg in 1 µL of 0.1% 
sodium metabisulfite diluted in 0.9% NaCl) was injected via stereotactic 
surgery, under deep anesthesia (tribromoethanol 300 mg/kg, i.p.), in two 
different regions of the right mid-striatum (2 × 2 µL, 0.5 µL/min), with the 
following coordinates in mm (Santini et al., 2007): (i) AP +1, ML -2.1, DV 
-3.2; and (ii) AP +0.3, ML -2.3, DV -3.2. 
Not all Parkinsonian animals develop LID (Cenci, 2007, Santini et 
al., 2007). Then we selected animals with severe hemiparkinsonism, which 
increases the risk of development of LID (Santini et al., 2007). Mice were 
challenged with R(-)-apomorphine (0.6 mg/kg, s.c.), and after cylinder 
habituation (10 min), the number of net rotations were evaluated in plastic 
tubes (19 cm diameter, 22 cm high, 30 min) using the video tracking 
system ANY-maze™ (Stoelting, USA). After four weeks of recovery from 
6-OHDA surgery, those animals with insufficient number of net rotations 
(> 2 counterclockwise rotations/min, fig.1B) (Nishimura et al., 2003) were 
discarded (around 20-30%/experiment). 
Selected mice were then individually housed in cages 
(28 × 17 × 13 cm) with free access either to running wheels (exercise 
group) or to locked versions of the same wheels (sedentary group). The 
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RW (RW 4½’’, Super Pet, USA) were fitted with electronic counters for 
distance and speed (Cunha et al., 2012). The locked wheels were used to 
avoid bias of environmental enrichment (EE) due to the introduction of 
objects (wheels) into mouse cages. Moreover, all wheels remained at the 
same fixed position in the cages to avoid spatial EE. 
In parallel to the exposure to the wheels (fig.1A), all sedentary and 
exercised mice were daily treated with a single intraperitoneal (i.p.) 
injection of L-DOPA methyl ester hydrochloride (25 mg/kg) (Pavon et al., 
2006) and benserazide hydrochloride (12.5 mg/kg), a peripheral DOPA 
decarboxylase inhibitor. L-DOPA/benserazide treatment and exposure to 
the wheels lasted two weeks. This protocol yielded the two experimental 
groups of interest, namely hemiparkinsonian (6-OHDA-treated mice 
exposed to L-DOPA) that were either (i) sedentary (SED, with locked 
wheel, n = 31) or (ii) exercised (RW, with unlocked running wheel, 
n = 28). 
 
2.2. Behavioral tasks 
Animals were habituated for 1 h in a sound and light (12 lx) 
attenuated room before behavioral tasks, which were carried out during the 
light phase of the cycle (10-17 PM). 
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Cylinder task was assessed in individual glass cylinders (12 cm 
diameter, 15 cm high) at three different times: (i) before 6-OHDA lesion, 
(ii) four weeks after 6-OHDA surgery and before L-DOPA/benserazide 
treatment, and (iii) two weeks after L-DOPA/benserazide treatment (twenty 
minutes after injection). We manually evaluated the number of forepaw 
contacts with the cylinder walls during 3 min. We only counted paw 
contacts with extended digits supporting the body weight. Results were 
expressed as the number of failures of injured paw (left paw, right striatum) 
as a % of total number of wall contacts, which represents an asymmetry 
score (contralateral bias) (Pavon et al., 2006). 
Abnormal involuntary movements (AIMs) were assessed in larger 
plastic tubes (19 cm diameter, 22 cm high) over a period of 120 min after 
two weeks of L-DOPA/benserazide treatment. AIMs were manually 
classified into: orofacial, forelimb, axial or dystonic, and locomotive 
(Video 1); and severity was scored for 1 min every 20 min using a 0-4 scale 
as previously defined (Lundblad et al., 2005, Pavon et al., 2006). The video 
tracking system ANY-maze™ (Stoelting, USA) was used for off-line rating 
of locomotive AIMs (rotations), where we also scored rearing and 
grooming, as conventional measures of motor activity. When testing the 
only approved antidyskinetic drug (Lundblad et al., 2005), Amantadine 
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hydrochloride (60 mg/kg, i.p.) was administered 90 min before L-
DOPA/benserazide injection. 
 
2.3. Biochemistry 
Forty min after the last L-DOPA/benserazide injection, striata and 
quadriceps muscle samples were dissected and freshly processed according 
to the procedures described below. Mice were also anesthetized 
(Pentobarbital 50 mg/kg, i.p.) and intracardially perfused with 
4% paraformaldehyde (PFA) in phosphate buffer (pH 7.4). Brains were 
post-fixed with 4% PFA (2 h) and 25% sucrose (24 h). 
Muscle mitochondrial activity was assessed by enzymatic activity of 
complex I enzyme corrected by citrate synthase (CS), or complex I/CS rate. 
Quadriceps femoris muscle was mechanically homogenized in 50 mM of 
phosphate buffered saline (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 
1.46 mM KH2PO4, pH 7.4) containing 0.3 M saccharose, 5 mM 3-(N-
morpholino)-propanesulfonic sodium salt (MOPS), 1 mM EGTA, and 0.1% 
bovine serum albumin. The homogenates were centrifuged (1000 × g, 10 
min, 4°C) and supernatant was centrifuged at 15000 × g in order to 
concentrate mitochondria in the pellet, which was dissolved in the same 
phosphate buffer (Latini et al., 2005). We then measured CS and complex I 
in mitochondria-enriched fractions (2 ml/mg protein) (Lowry et al., 1951). 
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Complex I activity was measured through ferricyanide reduction 
(ε = 1 mM−1 × cm−1, 30°C) at 420 nm (Cassina and Radi, 1996). CS activity 
was measured at 420 nm in 1 M potassium phosphate buffer (1 M KH2PO4 
and 1 M K2PO4, pH 7.4) containing 0.5 mM oxaloacetate, 0.31 mM acetyl-
CoA, 0.1 mM 5,5-dithiobis(2-nitrobenzoic acid), and 0.25% Triton X-100. 
Complex I and CS were calculated as nmol/min/mg protein. 
Immunohistochemistry (IHC). Protein extracts from striata were 
prepared as described (Aguiar et al., 2010) and proteins (20 µg) (Lowry et 
al., 1951) were separated by 10% SDS-PAGE gel electrophoresis and 
blotted onto a nitrocellulose membrane. Immunodetection was carried out 
using different polyclonal primary antibodies, namely rabbit anti- DARPP-
32 total, phospho-Thr(75) and phosphor-Thr(34) (1:1000, Cell Signaling®), 
rabbit anti- c-Fos (1:200, Merck®), or mouse anti- cyclin-dependent kinase 
5 (cdk 5) (1:200, Santa Cruz®). Immunoreactivity was visualized by 
enhanced chemiluminescence and quantified using ImageJ platform (1.44p, 
National Institute of Health). The IHC detection of tyrosine hydroxylase 
(TH), was carried out in free-floating coronal striatal sections (25 µm thick) 
using a standard avidin-biotin IHC protocol with a monoclonal primary 
antibody against TH (1:1000, IgG, Diasorin) (Prediger et al., 2010) and the 
IHC quantification was also quantified using the ImageJ platform. 
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High performance liquid chromatography (HPLC). Blood was 
collected immediately after anesthesia (Pentobarbital 50 mg/kg, i.p.) into 
an EDTA solution to allow the separation of plasma by centrifugation. The 
plasma was then neutralized (2 M KH2PO4/K2HPO4, pH 7.6) and re-
centrifuged (30000 × g, 15 min, 4°C). Aliquots (20 µl) were analyzed by 
reverse phase HPLC (Ultrasphere IP with particle size of 5 µm), using 
electrochemical detection, as previously described (Prediger et al., 2010). 
 
2.4. Statistical analysis 
Data are presented as mean ± standard error of the mean (SEM). The 
contralateral bias (%) has been transformed (cosine transform) to allow 
parametric statistical comparison. Student’s t-test, analysis of variance 
(ANOVA) and Bonferroni post-hoc test were used for comparisons of the 
means. The relation between AIMs and cdk5 was performed by Pearson’s 
linear regression. The accepted level of significance was p < 0.05. 
 
3. RESULTS 
Hemiparkinsonian mice allowed to freely exercise (RW) run 
maximal distances close to 1.5 km/day (fig.1C). These animals also 
displayed muscular adaptations to exercise training (Aguiar et al., 2008b), 
typified by a 17.7±4.2% increment (p < 0.05) of complex I/CS rate in the 
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skeletal muscle (462.3±18.4) when compared to sedentary (402.4±10.4); 
accordingly, during the weeks of exercise, these hemiparkinsonian mice 
doubled their average running speed and increased fourfold their maximum 
running speed (p < 0.05, fig.1D). These results demonstrate the increased 
muscle oxidative activity and exercise performance after 14 days of RW. 
 
3.1. Repeated L-DOPA administration improves 6-OHDA-induced motor 
deficits, but induces dyskinesia 
The hemiparkinsonian state of the 6-OHDA-treated mice was first 
confirmed using two different criteria: 1) first, while alive, mice were 
challenged with R(-)-apomorphine; 2) second, after being killed, we carried 
out an IHC analysis of striatal TH. As expected, hemiparkinsonian mice 
displayed a marked increase of R(-)-apomorphine-induced 
counterclockwise rotations in comparison to control (vehicle-injected) mice 
(p < 0.05, fig.1B). Also, 6-OHDA also caused a significant 83±4% 
decrease (p < 0.05) of the striatal TH immunostaining in the injected 
striatum in relation to contralateral unlesioned hemisphere, which was 
similar in sedentary (SED) (fig.2A) and exercised (RW) mice (fig.2B). 
We also confirmed that 6-OHDA-induced hemiparkinsonism was 
accompanied by a significative bradykinesia in the left forelimb, which was 
attenuated after L-DOPA/benserazide treatment (p < 0.05, fig.2C). 
  
13 
 
Additionally, the long-term treatment with L-DOPA induced the 
development of AIMs (fig.2D-F), as testified by the ability of Amantadine 
(60 mg/kg, i.p) to decrease the severity of LID (p < 0.05, fig.2D), thus 
confirming the dyskinetic phenotype of these abnormal movements. 
 
3.2. Exercise selectively reduces the development of L-DOPA-induced 
dyskinesia 
Exercise and L-DOPA/benserazide did not affect 6-OHDA-induced 
neurodegeneration, since SED and RW mice showed similar loss of TH 
immunoreactivity (sedentary = 0.16±0.8, RW = 0.18±0.7, arbitrary unities) 
in the striatum compared to the contralateral hemisphere (sedentary = 
0.98±0.6, RW = 0.96±0.8, arbitrary unities) (fig.2A-B). Also, another 
important factor predisposing to the development of LID, i.e. the plasma 
levels of L-DOPA (Lundblad et al., 2005, Cenci, 2007), was unaffected by 
exercise (SED 21.3 ± 1.4, RW 22.4 ± 2.4, µg/mL/kg body weight). 
Notably, hemiparkinsonian mice allowed to freely exercise presented less 
severe L-DOPA-induced axial and forelimb AIMs (p < 0.05, fig.2D-E) and 
less stereotyped rotations than SED animals (p < 0.05, fig.2F). However, 
the orofacial AIMs were not modified by exercise (fig.2E). Moreover, the 
discrete EE of locked wheels, however, did not alter the development of 
LID in SED animals (fig.2D-F). 
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These antidyskinetic effects were not associated with differences in 
overall motor function, since spontaneous locomotion was unaffected by 
exercise; in fact, rearing (SED 4 ± 0.6, RW, 3.3 ± 0.4) and grooming (SED 
6.5±0.4, RW 6.2±0.4) activities in the cylinder, as well as the distance 
travelled in the tube (SED 33 ± 5.3 m, RW 27.4 ± 4.2 m), were similar 
between SED and RW groups. 
 
3.3. Exercise attenuates striatal neurochemical changes associated to L-
DOPA-induced dyskinesia 
Cdk5 and DARPP-32 abnormal signaling is tightly associated with 
the phenotype of LID in murine (Andersson et al., 1999, Santini et al., 
2007). Accordingly, we confirmed a significative correlation between the 
severity of LID and the striatal levels of cdk5 (p < 0.05, fig.3A), which was 
increase in the lesioned striatum of SED (1.5 ± 0.1 arbitrary unities, a.u.). 
Notably the striatal cdk5 immunoreactivity of the lesioned striatum was 
reverted by exercise (0.9 ± 0.1 a.u. in RW mice) to similar levels to that 
found in the contralateral unlesioned hemisphere (SED 1 ± 0.2, RW 
1 ± 0.2). 
Chronic treatment with L-DOPA also increased the phosphorylation 
of Thr(34) and Thr(75) sites of DARPP-32 protein in the lesioned striatum 
of SED (p < 0.05, fig.3C); notably, this was restricted to Thr(75) site of 
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DARPP-32 in exercised mice (p < 0.05, fig.3C). Thus, exercise induced a 
significative decrease of Thr75/Thr34 phosporylation ratio in the dyskinetic 
animals (SED 1.46 ± 0.05, RW 1.19 ± 0.05, p < 0.05).  
Finally, we also confirmed that L-DOPA treatment increased c-Fos 
expression, a biomarker of neuronal activity (Liste et al., 1997), in the 
lesioned striatum of dyskinetic animals (p < 0.05, fig.3B). Notably, c-Fos 
levels were significantly lower in the lesioned striatum of 
hemiparkinsonian mice allowed to exercise (RW) in relation to SED 
(p < 0.05, fig.3). 
 
4. DISCUSSION 
The present study shows that exercise attenuates the development of 
LID, the main side-effect and limiting factor associated with the therapeutic 
management of PD (Parkes, 1981, Maurel et al., 2001). Furthermore, we 
provide evidence that this beneficial effect of exercise results from its 
ability to curtail the aberrant dopaminergic signaling in the striatum that is 
currently accepted to underlie LID (Andersson et al., 1999, Picconi et al., 
2003, Santini et al., 2007). The appearance of dyskinesia represents a 
challenge to PD therapy because it can be severe enough to warrant 
reducing the L-DOPA dose below optimal therapeutic levels (Pavon et al., 
2006). Interesting, earlier evidence had demonstrated increased efficiency 
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of suboptimal doses of L-DOPA in PD patients and MPTP-treated mice 
(Archer and Fredriksson, 2010, Frazzitta et al., 2012). These patients had 
milder dyskinesia, without any increase in motor symptoms (Frazzitta et 
al., 2012). Our results extend these findings by demonstrating that exercise 
can attenuate the development of LID in optimal doses of the drug. 
Evidence have consistently demonstrated benefits of exercise to 
brain (Cotman and Berchtold, 2002, Aguiar et al., 2008a), in particular to 
attenuate the burden of brain diseases, including PD (Petzinger et al., 2007, 
Teixeira et al., 2008, Aguiar et al., 2009). However, wheels also allow any 
exploration and interaction beyond running, such as climbing, chewing and 
digging, a form of EE. The literature shows several profiles of 
neuroplasticity in murine exposed to EE (Cotman and Berchtold, 2002). 
However, some authors suggest diminishing neuroplasticity changes in the 
absence of RW on the EE (van Praag et al., 2000). Our results are 
consistent with this evidence. In this work, the running motion was 
exclusive to RW group, as described in the Methods and Results section. 
Neurological benefits of exercise may also result from increased motor 
skills (McCloskey et al., 2001, Aguiar et al., 2009). Accordingly, we now 
report that exercised hemiparkinsonian animals ran more (increasing 
distances raced) and faster (increasing running speeds) than sedentary 
hemiparkinsonian controls (locked wheels), which is indicative of 
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increased athletic performance and motor control, respectively. 
Biomechanical analysis revealed a fine trunk and limbs coordination during 
these rapid movements (Walter, 2003); it was precisely trunk and limbs 
that benefited from the antidyskinetic effects of exercise, instead of face 
and tongue, which control is distributed through different corticostriatal 
loops (Holschneider et al., 2007). Furthermore, some authors have reported 
an increased efficacy of L-DOPA (Archer and Fredriksson, 2010, Ung et 
al., 2012), including in patients with PD (Reuter et al., 1999, Muhlack et 
al., 2007, Frazzitta et al., 2012), which could explain the benefitial effects 
of exercise. Moreover, our findings indicate that exercise did not affect the 
antiparkinsonian effects of L-DOPA in hemiparkinsonian animals, nor did 
it modify the plasma levels of L-DOPA in accordance with the lack of 
impact of exercise on the pharmacokinetics and pharmacodynamics of L-
DOPA in PD patients (Muhlack et al., 2007, Lopane et al., 2010). This 
supports the hypothesis that exercise may selectively rebalance the 
functioning of the basal ganglia to permit L-DOPA to partially restore 
dopaminergic tonus without development of LID. This contention is further 
supported by the ability of exercise to prevent the development of the 
cardinal neurochemical changes in the basal ganglia that are known to be 
associated with LID (Liste et al., 1997, Aguiar et al., 2010, VanLeeuwen et 
al., 2010, Aguiar Jr et al., 2012). 
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LID is associated with some characteristic neurochemical changes in 
the basal ganglia: it is dependent on the over-functioning of DA D1-like 
receptors in the striatopallidal MSNs (Aubert et al., 2005), leading to 
increased phosphorylation at threonine 34 of DARPP-32 and inhibition of 
PP-1 (Santini et al., 2007); this results in a loss of depotentiation and 
enhanced activation of the striatopallidal neurons (Picconi et al., 2003), 
typified increased to FosB expression (Pavon et al., 2006), which is 
currently considered the main neurophysiologic trait associated with LID in 
animal models of PD (Picconi et al., 2003, Santini et al., 2007). Active 
DARPP-32-Thr(34) enhances phosphorylation of NMDA receptors, which 
provides a rationale to understand the ability of Amantadine to achieve its 
long-term antidyskinetic effects, albeit its clinical use is limited by the side 
effects resulting from its interference with all forms of plasticity dependent 
on NMDA receptors (Lundblad et al., 2005). Further adding to this 
dyskinesia-associated unbalanced regulation of DARPP-32, a key 
integrator of the responsiveness of MSNs (Picconi et al., 2003), dyskinetic 
animals also present higher levels of cdk5 in the striatum (Aubert et al., 
2005), which phosphorylates DARPP-32 at threonine 75 and converts 
DARPP-32 into an inhibitor of protein kinase A (PKA) (Picconi et al., 
2003, Santini et al., 2007). The pharmacological and genetic manipulations 
to reduce the phosphorylation of DARPP-32 or PKA activity were also 
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successful in alleviating dyskinesia in hemiparkinsonian animals (Santini et 
al., 2007, Darmopil et al., 2009, Lebel et al., 2010). We now report that the 
dyskinetic mice able to self-exercise displayed a reduction of some of the 
key neurochemical features associated with dyskinesia, namely decreased 
Fos expression, decreased DARPP-32 phosphorylation and decreased cdk5 
activation in the striatum. Thus, voluntary exercise curtailed the activation 
of DARPP-32 at threonine 34. Furthermore, it decreased cdk5 activation 
and caused an even greater decrease of the phosphorylation pattern of 
DARPP-32 at threonine 75. This resulted in an expected decreased 
activation of the basal ganglia circuitry, as gauged by the decreased up-
regulation of c-Fos in dyskinetic mice able to exercise. Altogether, these 
observations further strengthen our contention that exercise is able to 
rebalance dopaminergic over-signaling in the striatum, thus curtailing the 
severity of LID.  
This key ability of exercise to normalize the over-sensitive 
dopaminergic signaling in MSNs is in notable agreement with evidence 
showing the ability of exercise to counteract drug-induced stereotyped 
behaviors affecting dopaminergic system, such as haloperidol-induced 
catalepsy (Klusha et al., 1983), apomorphine-induced rotations (Aguiar Jr 
et al., 2012), or yawning movements induced by either apomorphine (Dey 
and Singh, 1992) or reserpine (Teixeira et al., 2008). In all these abnormal 
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movements, exercise counteracted an aberrant functioning of the 
dopaminergic signalling in the basal ganglia. Future work ought to be 
undertaken to tackle the mechanisms by which exercise exerts this 
normalizing effect. A tentative possibility would be an ability of exercise to 
bolster the regeneration of the dopaminergic system blunted in PD, given 
that the presynaptic dopaminergic robustness in the striatum determines the 
susceptibility to LID (Picconi et al., 2003, Cenci, 2007). This hypothesis is 
heralded by the observations that exercise enhances the survival of 
dopaminergic neurons and increases neurogenesis in the striatum of animal 
models of PD (O'Dell et al., 2007, Yoon et al., 2007). This would be a tight 
analogy with the ability of exercise to attenuate memory impairment in 
Parkinsonism (Aguiar et al., 2009), which involves a growth factor 
mediated (reviewed in Cotman and Berchtold, 2002). An alternative 
hypothesis would be an impact of exercise on the glutamatergic afferents 
driving the basal ganglia, in accordance with the impact of exercise on the 
morpho-functional plasticity of glutamatergic synapses (Real et al., 2010, 
VanLeeuwen et al., 2010) that are known to be affected in dyskinetic 
animals (Kobylecki et al., 2010, Sgambato-Faure and Cenci, 2012). 
This association (L-DOPA plus exercise) is safe and used since the 
introduction of L-DOPA forty years ago (Blonsky and Minnigh, 1970, 
Mikkelsen et al., 1972). We suggest that exercise could interfere with 
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development of dyskinesia and abnormal striatal signaling after L-DOPA 
treatment. These findings can widen the symptomatic benefits of primary 
antiparkinsonian drug, L-DOPA. These data should be considered in future 
clinical studies involving PD, exercise and L-DOPA treatment. 
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Video and figure legends 
Video 1. L-DOPA-induced dyskinesia. 
Figure 1. (Panel A) Experimental design: all animals received a double 
intra-striatal administration of 6-OHDA (0 week) and experienced a typical 
hemiparkinsonism phenotype, revealed by increased counterclockwise 
rotations (4 weeks) (  p < 0.05 vs. vehicle, Student’s t-test, panel B). Mice 
were then separated in exercise (running wheels) or sedentary groups, and 
were simultaneously treated with L-DOPA/benserazide (4-6 weeks). 
Exercised mice improved motor skills, as showed by daily increased 
running distances and speeds (repeated measures ANOVA followed by 
Bonferroni post-hoc test, panels C and D). Data represent mean ± SEM for 
three independent experiments (n = 9-11 animals/group/experiment). * 
p < 0.05 versus vehicle (Student’s t-test). Abbreviations: R(-)-APO – R(-)-
apomorphine, 6-OHDA – 6-hydroxydopamine. 
 
Figure 2. Exercise and L-DOPA/benserazide (25/12.5 mg/kg, i.p.) showed 
no effect on neurodegeneration, evaluated as a decreased immunoreactivity 
of tyrosine hydroxylase in the lesioned striatum (A-B). Exercise also not 
changed the antiparkinsonian effects of L-DOPA (  p < 0.05 vs. baseline, 
# p < 0.05 vs. 4 weeks, repeated measures ANOVA followed by Bonferroni 
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post-hoc test, panel C). However, exercise effective in reducing LID 
(  p < 0.05 vs. SED, repeated measures ANOVA followed by Bonferroni 
post-hoc test, panels D and F), markedly for the AIMs of the limbs and 
trunk, but not orofacial (  p < 0.05, Student’s t-test, panel E). Data 
represent mean ± SEM for three independent experiments (n = 9-11 
animals/group/experiment). Abbreviations: AIMs – abnormal involuntary 
movements, CPu – Caudate-putamen, GPe – external globus pallidus, RW 
– running wheel, sc – corpus callosum, SED – sedentary, st – stria 
terminalis, 6-OHDA – 6-hydroxydopamine. 
 
Figure 3. The severity of L-DOPA-induced dyskinesia correlated with 
increased striatal levels of cdk5 (Pearson's correlation, panel A) and c-Fos 
(  p < 0.05 vs. control, # p < 0.05 vs. 6-OHDA, two-way ANOVA 
followed by Bonferroni post-hoc test, panel B), an indicative of enhanced 
neuronal activity. L-DOPA also triggered an hyperphosphorylation of 
DARPP-32 at Thr(34) and Thr(75) sites in sedentary mice (  p < 0.05 vs. 
control, # p < 0.05 vs. 6-OHDA, two-way ANOVA followed by Bonferroni 
post-hoc test, panel C). Notably, exercise (RW) decreased these 
neurochemical changes typically associated with L-DOPA-induced 
dyskinesia. Data represent mean ± SEM for two independent experiments 
(n = 6-8 animals/group/experiment). AIM – abnormal involuntary 
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movements, cdk5 – cyclin-dependent kinase 5, DARPP-32 – dopamine and 
cAMP-Regulated Phosphoprotein 32 kDa, RW – running wheel, SED – 
sedentary, Thr – threonine residue, 6-OHDA – 6-hydroxydopamine. 
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Long-term L-DOPA induced dyskinesia in hemiparkinsonian animals 
Voluntary exercise showed antidyskinetic effects 
The abnormal movements of the trunk and limbs were attenuated, but not 
orofacial 
Exercise prevented abnormal dopaminergic signaling in the striatum of 
dyskinetic mice 
 
